Successful treatment of pure red cell aplasia with rituximab in patients after ABO-compatible allogeneic hematopoietic stem cell transplantation

Case Reports in Oncology

Volumn 5, Issue 1, 2012, Pages 110-113

  Jung, Sung Hoon ^a   Ahn, Jae Sook ^a   Yang, Deok Hwan ^a   Park, Hyung Chul ^a   Bae, Soo Young ^a   Kim, Yeo Kyeoung ^a   Kim, Hyeoung Joon ^a   Lee, Je Jung ^a  

^a Chonnam National University Research Institute of Medical Sciences   (South Korea)

Author keywords

ABO compatibility; Allogeneic stem cell transplantation; Pure red cell aplasia; Rituximab

Indexed keywords

ALANINE AMINOTRANSFERASE; AMINOTRANSFERASE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PREDNISOLONE; RITUXIMAB; STEROID;

ABSENCE OF SIDE EFFECTS; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; BONE MARROW BIOPSY; CASE REPORT; CHRONIC GRAFT VERSUS HOST DISEASE; CYTOMEGALOVIRUS; DRUG DOSE REDUCTION; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN PARVOVIRUS B19; LIVER BIOPSY; PLASMAPHERESIS; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETICULOCYTE COUNT;

EID: 84860735464     PISSN: None     EISSN: 16626575     Source Type: Journal    
DOI: 10.1159/000337022     Document Type: Article

References (15)

1. Fisch P, Handgretinger R, Schaefer HE: Pure red cell aplasia. Br J Haematol 2000;111:1010-1022.
2. Sawada K, Hirokawa M, Fujishima N: Diagnosis and management of acquired pure red cell aplasia. Hematol Oncol Clin North Am 2009;23:249-259.
3. Helbig G, Stella-Holowiecka B, Wojnar J, et al: Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies. Ann Hematol 2007;86:677-683.
4. Deotare UR, Vishwabandya A, Mathews V, et al: Response to high-dose dexamethasone for acquired pure red cell aplasia following ABO-mismatched allogeneic stem cell transplantation. Bone Marrow Transplant 2006;37:1149-1150.
5. Roychowdhury DF, Linker CA: Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin. Bone Marrow Transplant 1995;16:471-472.
6. Sahovic EA, Flick J, Graham CD, et al: Case report: isoimmune inhibition of erythropoiesis following ABO-incompatible bone marrow transplantation. Am J Med Sci 1991;302:369-373.
7. Gmur JP, Burger J, Schaffner A, et al: Pure red cell aplasia of long duration complicating major ABO-incompatible bone marrow transplantation. Blood 1990;75:290-295.
8. Ohta S, Yokoyama H, Ise T, et al: Apheresis therapy for prolonged red cell aplasia after major ABO-mismatched bone marrow transplantation. Intern Med 1997;36:487-491.
9. Heyll A, Aul C, Runde V, et al: Treatment of pure red cell aplasia after major ABO-incompatible bone marrow transplantation with recombinant erythropoietin. Blood 1991;77:906.
10. Bavaro P, Di Girolamo G, Olioso P, et al: Donor lymphocyte infusion as therapy for pure red cell aplasia following bone marrow transplantation. Br J Haematol 1999;104:930-931.
11. Yang MH, Hsu HC: Pure red cell aplasia after ABO-incompatible allogeneic stem cell transplantation in severe aplastic anemia with response to steroids: a case report and literature review. Ann Hematol 2001;80:299-301.
12. McLaughlin P, Grillo-Lopez AJ, Link BK, et al: Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. J Clin Oncol 1998;16:2825-2833.
13. Zecca M, De Stefano P, Nobili B, et al: Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. Blood 2001;97:3995-3997.
14. Berentsen S: Rituximab for the treatment of autoimmune cytopenias. Haematologica 2007;92:1589-1596.
15. Maschan AA, Skorobogatova EV, Balashov DN, et al: Successful treatment of pure red cell aplasia with a single dose of rituximab in a child after major ABO incompatible peripheral blood allogeneic stem cell transplantation for acquired aplastic anemia. Bone Marrow Transplant 2002;30:405-407.